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Minimum Health Standards policy 
a b s t r a c t 
Background: COVID-19 initially caused less severe outbreaks in many low- and middle-income coun- 
tries (LMIC) compared with many high-income countries, possibly because of differing demographics, 
socioeconomics, surveillance, and policy responses. Here, we investigate the role of multiple factors on 
COVID-19 dynamics in the Philippines, a LMIC that has had a relatively severe COVID-19 outbreak. 
Methods: We applied an age-structured compartmental model that incorporated time-varying mobility, 
testing, and personal protective behaviors (through a “Minimum Health Standards” policy, MHS) to repre- 
sent the first wave of the Philippines COVID-19 epidemic nationally and for three highly affected regions 
(Calabarzon, Central Visayas, and the National Capital Region). We estimated effects of control measures, 
key epidemiological parameters, and interventions. 
Findings: Population age structure, contact rates, mobility, testing, and MHS were sufficient to explain the 
Philippines epidemic based on the good fit between modelled and reported cases, hospitalisations, and 
deaths. The model indicated that MHS reduced the probability of transmission per contact by 13-27%. 
The February 2021 case detection rate was estimated at ~8%, population recovered at ~9%, and scenario 
projections indicated high sensitivity to MHS adherence. 
Interpretation: COVID-19 dynamics in the Philippines are driven by age, contact structure, mobility, and 
MHS adherence. Continued compliance with low-cost MHS should help the Philippines control the epi- 
demic until vaccines are widely distributed, but disease resurgence may be occurring due to a combina- 
tion of low population immunity and detection rates and new variants of concern. 
Funding: This work was supported by the World Health Organization Regional Office for the Western 
Pacific. Tagalog translation of the abstract (Appendix 2). 
© 2021 Published by Elsevier Ltd. 
This is an open access article under the CC BY-NC-ND IGO license 
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Research in context 
Evidence before this study 
The ongoing COVID-19 pandemic has affected more than 
188 countries with variable impacts across settings, and ap- 
parently less severe outbreaks initially in many low- and 
middle-income countries (LMIC) compared with many high 
income countries. Understanding the reasons for these differ- 
ences is critical in determining how to ease restrictive non- 
pharmaceutical interventions (NPIs) without causing disease 
resurgence until vaccines are widely distributed. There are 
numerous factors that could drive these differences across 
countries, including population age structure, contact pat- 
terns, population density, seasonality, pre-existing exposure 
to other coronaviruses, comorbidities associated with poorer 
COVID-19 outcomes, healthcare and testing capacity, and in- 
tervention policies. Previous studies suggest that in LMIC, any 
benefits from factors like younger populations (due to lower 
susceptibility and infectiousness) may be negated by factors 
such as limitations in surveillance and healthcare capacity. If 
true, NPI timing and stringency could be expected to explain 
differences in COVID-19 burden across income settings. 
Added value of this study 
We explored the extent to which age structure, contact 
patterns, changes in mobility and personal protective behav- 
iors have driven the COVID-19 epidemic in the Philippines 
using a compartmental model and considered scenarios for 
future disease burden with policy changes. The model indi- 
cated that COVID-19 epidemiology in the Philippines can be 
explained by age, contact structure, mobility, and adherence 
to public health policies. The Minimum Health Standards pol- 
icy, which requires people to adopt a suite of personal pro- 
tective behaviors, has played a substantial role in reducing 
transmission in the Philippines. However, low testing capac- 
ity, the limited proportion of the population recovered from 
infection (modelled), and high sensitivity to easing policies, 
are likely to be important factors in determining the poten- 
tial for disease resurgence. 
Implications of all the available evidence 
Age and contact structures likely drive the substantial 
differences in COVID-19 burdens across income settings, 
but low-cost interventions can limit disease burden further. 
While numerous demographic, political, and socioeconomic 
factors are hypothesised to affect disease transmission, the 
results of this study suggest that, prior to the introduction 
of variants of concern, the apparent lower burden of dis- 
ease in the Philippines was driven by younger populations, 
contact structure, and policy. Using the Philippines as a case 
study, which experienced a relatively severe COVID-19 out- 
break for a LMIC, we investigated the effectiveness of NPIs 
and personal protective behaviors in curtailing transmission 
and found that personal protective behaviors have likely re- 
duced disease burden considerably. This study therefore pro- 
vides evidence of a low-cost, effective intervention policy 
that could be adopted by other countries to prevent disease 
resurgence while vaccines are distributed. 
NTRODUCTION 
Coronavirus disease of 2019 (COVID-19) epidemiology differs 
cross settings with apparently less severe initial outbreaks in 
any low- and middle-income countries (LMIC) compared with 
any high income countries (HIC) 1 , 2 , such that understanding why 
MIC are less affected is critical to understanding global epidemi- 
logy. Multiple demographic and socioeconomic factors likely drive 
ifferential COVID-19 burden across income groups, both within 
nd among countries. Expansive population pyramids and tropi- 2 al climates may reduce COVID-19 transmission and severe dis- 
ase in many LMIC 3–5 , while high contact rates, high prevalence 
f comorbidities, high population densities, and limited healthcare 
apacity could increase burden 6–10 . While many LMIC have had 
ower COVID-19 burdens than HIC, weak surveillance systems 11 
ould also affect epidemic estimates. Nonetheless, understanding 
hy many LMIC have had apparently less severe outbreaks could 
elp other countries better control their epidemics until vaccines 
re widely distributed. 
While there are now several highly efficacious vaccines to pre- 
ent severe disease 12 , 13 , and possibly infection 14 , 15 , from SARS- 
oV-2 (the virus that causes COVID-19), widespread vaccination 
ill take months to years 16 , 17 and will likely need to be coupled 
ith effective non-pharmaceutical interventions (NPIs) 18 . For coun- 
ries rolling out vaccines, easing NPIs too early could jeopardize 
uccess 18 . However, for the majority of the world’s population, par- 
icularly those living in LMIC, vaccine access and delivery is lim- 
ted 19 and widespread vaccination coverage may take two or more 
ears 17 , 20 . Thus, with or without vaccines, understanding the ef- 
ectiveness of NPIs that can curtail COVID-19 transmission is criti- 
al. There are three broad categories of NPIs, those that aim to: (i) 
solate infected individuals and their contacts; (ii) reduce contact 
etween infected and susceptible people (henceforward “macrodis- 
ancing”); and (iii) reduce transmission given contact between in- 
ected and susceptible people (henceforward “microdistancing”). 
ost HIC have enforced initiatives for all three types of NPIs with 
 focus on long, strict macrodistancing interventions through stay- 
t-home orders. LMIC have also employed macrodistancing poli- 
ies but often with shorter, less strict orders because these types 
f initiatives exacerbate poverty and have societal costs 21 , 22 that 
MIC cannot withstand (although some LMIC like China enforced 
trict, short-term macrodistancing policies that led to successful 
isease suppression). Relaxing of short-term macrodistancing poli- 
ies would be expected to lead to disease resurgence 23 , which runs 
ounter to the experience of some LMIC. A meta-analysis indicates 
hat inexpensive microdistancing policies (e.g., properly wearing 
ace masks) can be highly effective 24 and therefore could explain 
hy some LMIC are continuing to suppress transmission after an 
nitial period of macrodistancing. 
The Philippines is one of the most severely affected countries 
y COVID-19 in the Western Pacific Region 25–27 . Here we inves- 
igate COVID-19 epidemiology in the Philippines during the first 
ave of transmission and the effectiveness and sensitivity to mi- 
rodistancing policies. The Philippines is a LMIC that, during the 
rst epidemic wave, had over 580,0 0 0 confirmed cases and more 
han 12,0 0 0 deaths, with a peak in incidence in August 2020; at 
ime of writing, the Philippines is undergoing a subsequent sec- 
nd, more severe wave of transmission that is not assessed in this 
tudy. Various NPIs have been implemented in the country, with 
he timing and level of restriction varying by region. The NPIs im- 
lemented include different levels of community quarantines, in- 
luding school closures 28 . Between October 2020 and March 2021, 
he Philippines shifted from a focus on community quarantine or- 
ers towards greater reliance on Minimum Health Standards (MHS) 
olicies, requiring the proper use of face coverings, physical dis- 
ancing, and hand hygiene. To gain insights into the Philippines 
pidemic during the first wave of transmission, we present a data- 
riven COVID-19 model, which includes age structure, heteroge- 
eous contact patterns, time-varying testing rates, and macro- and 
icrodistancing. We use this model to 1) estimate epidemiological 
arameters for COVID-19 in the Philippines; 2) consider the effects 
f NPIs implemented during the first wave of transmission; and 3) 
reate scenarios for various policy changes and estimate associated 
isk of disease resurgence. 
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Figure 1. Age-structured COVID-19 model informed with population size, contact rates, and mobility from the Philippines. (A) Starting population age distribution used in the 
Philippines national model. (B) Unstratified model structure, coloured by infectious state (blue = non-infectious; pink = moderately infectious; red = highly infectious). (C) 
Stratification by infection and detection status (same colour scheme as in A) for actively infectious exposed and infected compartments. (D) Heterogeneous mixing matrices 
by age in the absence of NPIs (brighter colours indicate higher average number of contacts per day). (E) Community quarantine driven mobility adjustments applied to the 
mixing matrices (before seven-day moving average smoothing). Other locations include average from retail and recreation, supermarket and pharmacy, parks, and public 
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We used several data sources from the Philippines to assess 
OVID-19 epidemiology at the national level and for three highly 
ffected regions: Calabarzon (Region IV-A), Central Visayas (Region 
II), and the National Capital Region (Metro Manila). For national 
nd regional population data, we used the 2020 projected popu- 
ation distribution by age from the Philippines Statistics Authority 
 Figs. 1 A, S4). To gain insight into the first wave of transmission in
he Philippines, we used time series data from 1 March 2020 to 23 
ebruary 2021. We aggregated these data across all age groups (for 
ata sources where age was available), because data were sparse 
or certain age groups and > 20 0 0 records were missing age in-
ormation. For number of tests, ICU occupancy, and deaths, we 
sed daily data from the Republic of the Philippines Department 
f Health COVID-19 Data Drop ( https://doh.gov.ph/covid19tracker ). 
e aggregated test data from multiple laboratories (we list the 
aboratory facilities associated with each region in Table S6). For 
aily confirmed cases, we used the Department of Health COVID- 
9 Philippines Local Government Units Monitoring Platform ( https: 
/fassster.ehealth.ph/covid19/ ). Lab facilities in the Philippines con- 
rmed cases by RT-PCR and we calculated daily cases based on re- 
ort date. To account for differences between weekday and week- 
nd reporting, we smoothed daily confirmed cases using a seven 
ay moving average. To quantify changing mobility patterns associ- 
ted with NPIs, we used Google mobility data ( https://www.google. 
om/covid19/mobility/ ). a
3 odel 
We developed an age-structured deterministic compartmental 
odel of SARS-CoV-2 viral transmission to model disease spread 
n the Philippines. We included six sequential compartments in 
he model representing susceptible, non-infectious exposed, infec- 
ious exposed, early actively infectious, late actively infectious, and 
ecovered/removed persons ( Figs. 1 B, S1; Table 1 ), and stratified 
he infectious compartments by detection status and disease sever- 
ty ( Figs. 1 C, S2-3; we show differential equations in supplemen- 
al material). Similar SEEIIR model frameworks have been used for 
ther studies on COVID-19 29 , 30 and influenza 31 . To account for age- 
ependent processes, we stratified all model compartments by age 
roup using 5-year age bands from birth to ≥75 years of age and 
llowed the proportion symptomatic, susceptibility to infection, in- 
ection fatality rate, and the probability of hospitalisation to differ 
y age group. To introduce heterogeneous mixing by age, we incor- 
orated synthetic mixing matrices developed by Prem et al. 2017 32 
 Fig. 1 D). 
We considered several inter-compartmental transition rates to 
epresent epidemiologically important processes. To estimate dis- 
ase incidence, detected cases, hospitalisation, and ICU admission 
ates, we quantified transitions between different exposed and in- 
ectious compartments within the model ( Fig. 1 B-C, supplemen- 
al material). To calculate a modelled case detection rate, we cal- 
ulated the proportion of symptomatic cases that were detected 
 Fig. 1 C). We related the case detection rate (CDR t where t = time)
o the daily number of per capita tests performed using an expo- 
ential function, under the assumption that a certain testing rate is 
ssociated with a specific case detection rate (with this parameter 
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Table 1 
Compartments of the epidemiological model, indicating the stage of infection for different proportions of the population. 
Compartment Definition 
S Susceptible to infection. 
E n Non-infectious exposed, representing infected individuals in the non-infectious phase of the incubation period. 
E i Infectious exposed, representing infected individuals in the “presymptomatic” phase of the incubation period where onward transmission can occur. 
I e Early actively infectious, individuals are transmitting disease but not (yet) detected. 
I l Late actively infectious, symptomatic individuals are detected (for those whom detection does occur) and isolation and hospitalisation occurs. 
R Recovered and removed (i.e., dead). 
Table 2 
Key parameter prior and posterior distributions from the Philippines model. All parameters with the term “adjuster” allow for modification to the best estimates 
from the literature. Adjuster values are multiplicative factors applied to the odds ratio. An adjuster value of one indicates no adjustment is needed, a value 
below one indicates the parameter is lower in the Philippines, and a value above one indicates the parameter is higher in the Philippines. MHS is the Minimum 
Health Standards and refers to the microdistancing function that proportionally reduces the probability of transmission given contact. 
Parameter Prior distribution Prior distribution parameters Posterior credible interval centiles 
2.5th 50th 97.5th 
Incubation period (days) Truncated normal Mean 5.5, standard deviation 0.97, truncated 
range [1, infinity) 
3.70 5.42 7.36 
Duration actively infectious (days) Truncated normal Mean 6.5, standard deviation 0.77, truncated 
range [4, infinity) 
5.19 6.49 7.95 
Infection risk per contact Uniform Range 0.02-0.04 0.029 0.033 0.038 
Symptomatic proportion adjuster Uniform Range 0.5-2.0 0.589 1.23 1.91 
Infection fatality adjuster Uniform Range 0.5-2.0 0529 1.07 1.91 
hospitalisation proportion adjuster Uniform Range 0.5-2.0 0.588 1.34 1.96 
Maximum effect of MHS (proportion) Uniform Range 0.1-0.6 0.13 0.20 0.27 
Case Detection Rate at testing rate of 
1 test per 10,000 per day (proportion) 
Uniform Range 2-20 2.88% 9.81% 19.3% 



































































aried in calibration): 
D R t = 1 − ex p 
−b∗ test s t 
10 , 0 0 0 
on-pharmaceutical interventions 
We simulated community quarantines (e.g., business closures 
nd working from home) by varying the relative contribution of 
our locations to an overall age-specific dynamic mixing matrix 
 Figs. 1 D). Using Google mobility data, we scaled the household 
ontribution to the matrix with residential mobility; the work con- 
ribution with workplace mobility; and the contribution from other 
ocations (contacts outside of schools, homes, and work) with av- 
rage mobility from all other Google mobility locations ( Fig. 1 E, 
4). We simulated school closures by scaling school contribution 
ccording to the proportion of children attending schools under 
elevant policies. When schools closed, home contacts scaled up 
ith residential Google mobility data, although in reality, scaling 
p home contacts beyond the average household size may not 
trongly affect transmission due to contact saturation (i.e., the ceil- 
ng effect of the limited number of potential contacts to infect 
ithin each household). In the Philippines, school closures started 
n mid-March 2020 in the most highly affected areas and schools 
emain closed throughout the country (as of 10th May 2021). 
We simulated MHS as a scaled function that proportionally re- 
uces the probability of transmission given contact (reducing the 
robability of an infected person passing on the infection and the 
robability of a contact being infected). We allowed the function to 
cale from zero when we assumed minimal compliance with MHS 
15th August 2020) to a maximum value estimated by the cali- 
ration process (described below) when MHS was widely adopted 
15th November 2020). 
alibration 
We calibrated the model to data to reproduce local COVID-19 
ynamics and evaluated estimations of key epidemiological param- 
ters ( Table 2 ). We used three sources of local data as calibration
argets: total daily confirmed cases and the most recent estimate of 4 CU occupancy and cumulative deaths (806 and 11523 respectively 
or the national model). Although we calibrated the model to these 
hree targets simultaneously, we prioritized confirmed cases in the 
alibration process because these data are considered the highest 
uality in the Philippines for COVID-19 (based on advice from local 
ealth officials), while limiting the use of ICU and mortality data 
o the most recent values, as the quality of these data improved 
ver time. We simultaneously fit the model to the three calibra- 
ion targets using an adaptive Metropolis algorithm 33 ( Table 2 ; 
upplemental material). For the prior distributions of epidemio- 
ogical calibration parameters, we used uniform priors for highly 
ncertain quantities and truncated normal distributions for quan- 
ities informed by epidemiological evidence ( Table 2 ; supplemen- 
al material). To account for potential differences between HIC and 
MIC, we included “adjuster” parameters to modify the proportion 
f symptomatic individuals, proportion of symptomatic individu- 
ls hospitalised, and the infection fatality rate (which are based on 
stimates from HIC). The adjuster values are multiplicative factors 
pplied to the odds ratio, where an adjuster value of one would 
ndicate no adjustment is needed, a value below one would indi- 
ate the parameter is lower in the Philippines, and a value above 
ne would indicate the parameter is higher in the Philippines. To 
alibrate the model, we ran seven independent chains with ap- 
roximately 10 0 0 0 iterations per chain and discarded the first 200 
terations as burn-in. We evaluated convergence and autocorrela- 
ion through visual inspection of trace plots and autocorrelograms 
espectively, and calculated effective sample sizes. We used Latin 
ypercube Sampling across the multidimensional parameter space 
o select initial parameter conditions. We structured the model, 
alibration data, likelihood function, and priors identically for the 
ational and regional models. We report the model outputs as 
edian estimates with 25-75 and 2.5-97.5 credible interval per- 
entiles to show uncertainty. 
cenarios 
We ran scenarios with different policy changes to estimate fu- 
ure COVID-19 transmission and potential for disease resurgence 



















































































































ith easing different interventions. The baseline scenario held mo- 
ility and MHS constant based on the most recent date of data 
26th February 2021) through the end of the scenario period (31st 
ecember 2021). All scenarios began on 27 th February 2021. We 
imulated 50% return of onsite workers by increasing the relative 
ontribution of workplace mobility in the overall age-specific mix- 
ng matrix from current levels to current levels plus half the dif- 
erence between current workplace mobility and pre-COVID work- 
lace mobility. We simulated school reopenings by scaling school 
ontribution in the overall age-specific mixing matrix from zero to 
ne on the scenario start date to reflect full school attendance. To 
stimate the effect of easing MHS by 50, 70, and 100%, we de- 
reased the microdistancing function, which reduces the values of 
ll elements of the mixing matrices by a certain proportion, to 0.5, 
.3, and 0.0, respectively. We report the scenarios as median values 
ith 25-75 and 2.5-97.5 percentiles to show uncertainty. 
ole of the funding source 
The funding source of this study facilitated collaboration, 
elped to define the research questions, and assisted with inter- 
retation, but had no role in model development, parameterisation, 
nd methodological aspects of the study. 
ESULTS 
pidemiological fit 
The model reproduced national and regional trends in con- 
rmed cases, hospitalisations, and deaths when incorporating 
hanges in movement and adherence to MHS. Prior to assessing 
odel fit to data, we determined that the model converged by vi- 
ually assessing trace plots (e.g., Fig S5 for parameters in the na- 
ional model) and calculated effective sample sizes of 1170 for the 
ational model, 869 for Calabarzon, 1139 for Central Visayas, and 
513 for the National Capital Region. The model fit was consid- 
rably better with the inclusion of both community quarantine- 
djusted movement and adherence to MHS compared with a 
ounterfactual scenario that only included community quarantines 
 Figs. 2 , S6-8). These results suggest that if MHS had not been im-
lemented, there would have been twelve times as many cases at 
he August 2020 outbreak peak. The four calibrated models (na- 
ional and three regional models) show reasonably good fits to to- 
al confirmed cases ( Figs. 2-3 ). Additionally, the distributions are 
imilar for modelled and confirmed cumulative cases by age group, 
ith very close correspondence for those aged 40 years and above, 
ut underpredictions for those aged 25-39 and overpredictions for 
ges 19 and below (Fig. S9). The models slightly overpredict re- 
orted cumulative deaths and ICU occupancy (except for the Na- 
ional Capital Region) ( Figs. 4 , S10-12). We estimated the propor- 
ion of the population recovered by the end of the first wave of 
ransmission as approximately 9% (95% CI = 4-31%) as of 26th 
ebruary 2021 ( Fig. 4 ). 
arameter and case detection estimation 
We estimated key epidemiological parameters and transition 
ates ( Table 2 ; Fig. S13). We incorporated parameters to adjust the 
roportion of symptomatic individuals, the proportion of symp- 
omatic individuals hospitalised, and the infection fatality rate 
rom the baseline values and estimated all three adjuster param- 
ters had broad distributions overlapping one, indicating that the 
rocess of fitting to data did not provide information on the ad- 
ustments needed to these quantities. The maximum effect of MHS 
as estimated at around 0.20 (95% CI = 0.12 - 0.27) with a tight 
osterior distribution (Fig. S13), suggesting that MHS has reduced 5 he risk of transmission per contact by about 20%. The model case 
etection was estimated at approximately 2 to 15% in the Philip- 
ines (Fig. S14), although the posterior distribution of this value 
as broad (Fig. S13). 
cenario projections 
We projected transmission in the near term under a range 
f possible scenarios and show that, prior to the second epi- 
emic wave, epidemic trajectories were highly sensitive to compli- 
nce with MHS. Moreover, allowing home workers to return on- 
ite while maintaining MHS was estimated to have limited im- 
act on detected cases ( Figs. 5 , S15-17), as well as overall inci-
ence, hospital occupancy, and mortality (although the projections 
id not account for potentially increased transmission within con- 
ained spaces during the work week). If current conditions were 
arried forward, transmission was projected to continue at low lev- 
ls and therefore would not overwhelm hospital capacity or lead 
o excessive deaths. Allowing students to return to school was es- 
imated to result in a considerable increase in cases (although this 
esult varied markedly by region, Figs. S15-17). Reducing the effec- 
iveness of MHS by 50% was projected to lead to a steady increase 
n burden, whereas reducing the effectiveness of MHS by 70% or 
00% was projected to lead to a major resurgence in cases, associ- 
ted hospitalisations, and deaths. 
ISCUSSION 
The combination of younger age distributions, more intergener- 
tional contacts, changes in mobility, and changes in personal pro- 
ective behaviors, appear to explain why the Philippines sustained 
 relatively less severe COVID-19 outbreak than many high in- 
ome countries (HIC), prior to the introduction of variants of con- 
ern 34 , 35 . Younger populations typical of LMIC may reduce disease 
urden in two ways: 1) a proportionally smaller percent of the 
opulation is elderly (compared with HIC) and at highest risk of 
evere disease and mortality from COVID-19 3 , 4 ; and 2) those who 
urvive to old age are often of higher socioeconomic status and 
ay have a disproportionately lower infection risk compared with 
he general population 36 . More intergenerational contacts in LMIC 
ay also lower disease burden because elderly people often reside 
ith family rather than in aged-care facilities, which have driven 
utbreak clusters in many HIC (e.g., [37] ). An important finding of 
his study is that adherence to MHS appeared largely responsible 
or limiting transmission in the Philippines while gradually eas- 
ng quarantines during the first epidemic wave. These results were 
onsistent across regions (i.e., all models presented in this paper) 
hat span a wide population density gradient, suggesting that this 
pproach is effective in both rural and urban areas and could also 
e effective in other similar settings. It is possible that the effect of 
HS is a surrogate for other time-varying processes, however, local 
xperts within the Philippines provide strong intuition that MHS is 
esponsible for driving the patterns we found. In addition, we are 
ot aware of any other processes than those modelled that could 
e responsible for these patterns. These types of personal protec- 
ive measures will likely continue to be needed throughout 2021 
nd potentially 2022, depending on the speed of vaccine distribu- 
ion. 
Current transmission trends in the Philippines (as of 10th 
ay 2021) indicate that the country is in the middle of a sec- 
nd, larger wave of transmission and sustained disease spread re- 
ains a major threat until vaccines are widely distributed. Lo- 
al expert opinion suggests the second wave is mainly occurring 
n the National Capital Region and parts of Calabarzon and are 
riven by new variants of concern 34 , which are more transmissible 
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Figure 2. Model reproduced daily confirmed case count better with the inclusion of Minimum Health Standards (MHS). We calibrated the national model to daily confirmed 
cases (black dots; same in both plots), which included MHS (left) and ran a counterfactual scenario that did not include MHS (right). The MHS effect value (i.e., reduced 
transmission risk per contact) is squared in the model to account for the reduction in the probability of an infected person passing on the infection and the probability of a 
contact being infected, prior to adjustment of each cell of the mixing matrix. We provide results for the regional models with and without MHS in Figs. S6-8. 
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Counterfactual (MHS not incorporated) 
May 2020 Aug 2020 Nov 2020 Feb 2021 
National Capital Region 
Apr 2020 Jul 2020 Oct 2020 Jan 2021 nd lethal 38 . Further, increases in mobility, due to relaxed inter- 
onal travel requirements, and lower compliance to MHS (which 
ould be attributable to over-confidence in disease control and fa- 
igue with personal protective behaviors), provides more transmis- 
ion opportunities. The results of this study provided real-time 
eekly updates of the model outputs through the first wave di- 
ectly to policy-makers through the Department of Health COVID- 
9 Philippines Local Government Units Monitoring Platform ( https: 
/fassster.ehealth.ph/covid19/ ) and indicated that, in the absence 
f new variants, relaxing societal restrictions like work-from-home 
rders were not predicted to cause substantial disease resurgence. 
t the same time, low case detection (2-15%) and percentage re- 
overed (modelled at < 31%) and high sensitivity to maintaining 
HS indicated that disease resurgence remained a major threat. 
hus, prior to the introduction of disease variants, MHS may have 
een sufficient to sustain suppression of transmission as a bridge 
o broad scale vaccination. Although not modelled in this study, 
he increased transmissibility of the new variants may be broadly 
omparable to the reduction in transmission gained by MHS ad- 
erence. Therefore, these measures may no longer be sufficient to 
uppress transmission as strain replacement occurs, although they 6 ould still help alleviate burden on the health care system. Re- 
ent disease resurgence in the Philippines demonstrates the need 
or sustained non-pharmaceutical interventions until vaccines are 
idely distributed. Limited testing is another major obstacle for 
he Philippines 39 and many other LMIC and can hinder both public 
ealth response and our understanding of the epidemic. 
There are several important limitations relevant to interpret- 
ng the model results, including modelling assumptions, data lim- 
tations, and uncertainty. Most epidemiological parameters for 
OVID-19 used in this study were estimated from HIC (or China). 
hile we included “adjuster” parameters to allow the symptomatic 
roportion, hospitalisation, and mortality rates to vary for the 
hilippines (similar to [40] ), these parameters were not well con- 
trained by the data. We assumed that other parameters were sim- 
lar to HIC, which may be inaccurate. However, most parameter 
stimates appear reasonable given previously reported COVID-19 
pidemiology in the Philippines 26 . When more data become avail- 
ble from the Philippines or similar settings, the current model 
an be updated with new parameter values. Data issues made 
odelling and understanding the epidemic in the Philippines par- 
icularly challenging, although data quality has progressively im- 
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Figure 4. Model estimated epidemic indices from the calibrated Philippines model. Note that only the most recent estimate of cumulative deaths and ICU occupancy were 
included in the likelihood function, with the other time points presented as validation. ICU occupancy data was considered to have improved over the course of the epidemic. 
We provide equivalent regional model outputs in Figs. S10-12. 
Figure 5. Epidemic scenario projections for detected cases from the Philippines national model, showing high sensitivity to compliance with the Minimum Health Standards 
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reated specifically for COVID-19 in the Philippines and were not 
equired to report usage, likely affecting these estimates, especially 
arly in the epidemic. Similarly, daily deaths, which are often con- 
idered the most reliable epidemic indicator internationally, have 
uctuated markedly over the course of the epidemic, often peak- 
ng at times that appear contradictory to patterns of confirmed 
ases. Although reporting of daily deaths appears unreliable, cu- 
ulative deaths align reasonably well with the model projections 
f mortality without significant modification to the internation- 
lly estimated infection fatality rate. Finally, there is uncertainty 
round all model parameters, with some parameters less well con- 
trained than others (e.g., case detection rate), which highlights the 
d
7 eed for more epidemiological information. Future studies could 
uild on this effort by including new, more robust data sources for 
odel parameters and calibration targets. 
ONCLUSION 
One of the most critical issues facing countries around the 
orld is determining the best strategy for ending COVID-19 
ransmission through the combined use of vaccines and non- 
harmaceutical interventions. More than 188 countries have been 
ffected by COVID-19 with apparently less severe impacts in many 
MIC compared with HIC. Our results suggest that COVID-19 epi- 
emiology in the Philippines can be explained by differences in 















































































ge, contact structures, and policy, with MHS playing a substantial 
ole in mitigating the initial outbreak. The Philippines has expe- 
ienced one of the largest outbreaks of COVID-19 in the Western 
acific Region but also provides an approach that could help other 
ountries relax interventions more safely, which remains an impor- 
ant strategy for countries with limited access to vaccines. 
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